The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 15 Aug 2006
doi: 10.1242/jcs.03090
Research Article
Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23
Sandeep S. Negi
and
Mark O.J. Olson*
* Author for correspondence (e-mail: molson{at}biochem.umsmed.edu)
B23 (or nucleophosmin, NPM) is a multifunctional protein involved in ribosome biogenesis, control of centrosome duplication and in sensing cellular stress. It is phosphorylated during interphase by casein kinase 2 (CK2) and during mitosis by cyclin-dependent kinase (CDK). In this study we have addressed the role of these phosphorylation events in the dynamics and location of protein B23. Mutation of the CK2 phosphorylation site to alanine results in slower recovery of the mutant compared with the wild-type protein as measured by fluorescence recovery after photobleaching (FRAP). Immunofluorescence studies using an antibody against phosphorylated Thr199 revealed that B23 is phosphorylated at this CDK1 site at the start of mitosis and is dephosphorylated during anaphase. The CDK1-type phosphorylation sites are in the nucleic acid binding region of B23 and may contribute to its dissociation from the nucleolus during mitosis. A Thr to Glu mutant of the CDK1-type sites as well as other members of the nucleoplasmin family that lack the C-terminal nucleic-acid-binding region showed a greater mobility and/or faster recovery than wild-type B23.1, the longer variant. These results provide evidence that phosphorylation at these sites reduces the affinity of B23 for nucleolar components and might be a factor in regulating its location during the cell cycle.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Perera, H. G. Farina, J. Gil, A. Rodriguez, F. Benavent, L. Castellanos, R. E. Gomez, B. E. Acevedo, D. F. Alonso, and S. E. Perea
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity
Mol. Cancer Ther.,
May 1, 2009;
8(5):
1189 - 1196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Okuwaki
The Structure and Functions of NPM1/Nucleophsmin/B23, a Multifunctional Nucleolar Acidic Protein
J. Biochem.,
April 1, 2008;
143(4):
441 - 448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zou, J. Wu, R. J. Giannone, L. Boucher, H. Du, Y. Huang, D. K. Johnson, Y. Liu, and Y. Wang
Nucleophosmin/B23 Negatively Regulates GCN5-dependent Histone Acetylation and Transactivation
J. Biol. Chem.,
February 29, 2008;
283(9):
5728 - 5737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Gunawardena, B. L. Ruis, J. A. Meyer, M. Kapoor, and K. F. Conklin
NOM1 Targets Protein Phosphatase I to the Nucleolus
J. Biol. Chem.,
January 4, 2008;
283(1):
398 - 404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Meng, Q. Zhu, and R. Y. L. Tsai
Nucleolar Trafficking of Nucleostemin Family Proteins: Common versus Protein-Specific Mechanisms
Mol. Cell. Biol.,
December 15, 2007;
27(24):
8670 - 8682.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Falini, I. Nicoletti, N. Bolli, M. P. Martelli, A. Liso, P. Gorello, F. Mandelli, C. Mecucci, and M. F. Martelli
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias
Haematologica,
April 1, 2007;
92(4):
519 - 532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Falini, I. Nicoletti, M. F. Martelli, and C. Mecucci
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features
Blood,
February 1, 2007;
109(3):
874 - 885.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
